Literature DB >> 30381441

Nicotine-N'-Oxidation by Flavin Monooxygenase Enzymes.

Yadira X Perez-Paramo1, Gang Chen1, Joseph H Ashmore1, Christy J W Watson1, Shamema Nasrin1, Jennifer Adams-Haduch2, Renwei Wang2, Yu-Tang Gao3, Woon-Puay Koh4,5, Jian-Min Yuan2,6, Philip Lazarus7.   

Abstract

BACKGROUND: The major mode of metabolism of nicotine is by hydroxylation via cytochrome P450 (CYP) 2A6, but it can also undergo glucuronidation by UDP-glucuronosyltransferases and oxidation by flavin monooxygenases (FMO). The goal of this study was to examine the potential importance of FMOs in nicotine metabolism and assess the potential impact of missense polymorphisms in active FMOs on nicotine-N'-oxide (NOX) formation.
METHODS: Urine samples from 106 current Chinese smokers were analyzed for nicotine metabolites by mass spectrometry. Wild-type FMOs 1-5 and their most prevalent nonsynonymous variants were cloned and overexpressed in HEK293 cells, and were tested in oxidation reactions against nicotine.
RESULTS: A strong inverse correlation was observed between the ratio of urinary 3'-hydroxycotinine/cotinine, a measure of CYP2A6 activity, and the urinary levels of NOX alone (r = -0.383; P < 0.001) or NOX measured as a ratio of total nicotine metabolites (r = -0.414; P < 0.001) in smokers. In addition to FMO1 and FMO3, the functional FMO2427Q isoform was active against nicotine, whereas FMO4 and FMO5 exhibited low activity against nicotine (K m > 5.0 mmol/L). Significant (P < 0.05) decreases in N'-oxidation activity (V max/K m) were observed for the FMO1I303V, FMO3N61S, FMO3D132H, FMO3V257M, and FMO3E308G variants in vitro when compared with their respective wild-type isoforms; the truncated FMO2Q472stop isoform exhibited no enzyme activity.
CONCLUSIONS: These data indicate that increases in nicotine-N'-oxidation occur in subjects with deficient CYP2A6 activity, and that several FMO enzymes are active in nicotine-N'-oxidation. IMPACT: Several common missense FMO variants are associated with altered enzyme activity against nicotine and may play an important role in nicotine metabolism in low-CYP2A6 activity subjects. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30381441      PMCID: PMC6363832          DOI: 10.1158/1055-9965.EPI-18-0669

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  49 in total

1.  Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China.

Authors:  J M Yuan; R K Ross; X D Chu; Y T Gao; M C Yu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-07       Impact factor: 4.254

2.  Singapore Chinese Health Study: development, validation, and calibration of the quantitative food frequency questionnaire.

Authors:  J H Hankin; D O Stram; K Arakawa; S Park; S H Low; H P Lee; M C Yu
Journal:  Nutr Cancer       Date:  2001       Impact factor: 2.900

3.  Three haplotypes associated with CYP2A6 phenotypes in Caucasians.

Authors:  Michael Haberl; Birgit Anwald; Kathrin Klein; Regina Weil; Christine Fuss; Akçahan Gepdiremen; Ulrich M Zanger; Urs A Meyer; Leszek Wojnowski
Journal:  Pharmacogenet Genomics       Date:  2005-09       Impact factor: 2.089

4.  Immunoquantitation of FMO1 in human liver, kidney, and intestine.

Authors:  C K Yeung; D H Lang; K E Thummel; A E Rettie
Journal:  Drug Metab Dispos       Date:  2000-09       Impact factor: 3.922

5.  Benzydamine N-oxidation as an index reaction reflecting FMO activity in human liver microsomes and impact of FMO3 polymorphisms on enzyme activity.

Authors:  E Störmer; I Roots; J Brockmöller
Journal:  Br J Clin Pharmacol       Date:  2000-12       Impact factor: 4.335

6.  Phenotyping of flavin-containing monooxygenase using caffeine metabolism and genotyping of FMO3 gene in a Korean population.

Authors:  C S Park; W G Chung; J H Kang; H K Roh; K H Lee; Y N Cha
Journal:  Pharmacogenetics       Date:  1999-04

7.  Ethnic differences in allelic frequency of two flavin-containing monooxygenase 3 (FMO3) polymorphisms: linkage and effects on in vivo and in vitro FMO activities.

Authors:  Chang-Shin Park; Ju-Hee Kang; Woon-Gye Chung; Hyun-Gyu Yi; Jae-Eun Pie; Dong-Kyun Park; R N Hines; D G McCarver; Young-Nam Cha
Journal:  Pharmacogenetics       Date:  2002-01

8.  Importance of UDP-glucuronosyltransferase 1A10 (UGT1A10) in the detoxification of polycyclic aromatic hydrocarbons: decreased glucuronidative activity of the UGT1A10139Lys isoform.

Authors:  Ryan W Dellinger; Jia-Long Fang; Gang Chen; Rebecca Weinberg; Philip Lazarus
Journal:  Drug Metab Dispos       Date:  2006-03-01       Impact factor: 3.922

9.  Glucuronidation of nicotine and cotinine by UGT2B10: loss of function by the UGT2B10 Codon 67 (Asp>Tyr) polymorphism.

Authors:  Gang Chen; Andrea S Blevins-Primeau; Ryan W Dellinger; Joshua E Muscat; Philip Lazarus
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

10.  Nicotine dependence is associated with functional variation in FMO3, an enzyme that metabolizes nicotine in the brain.

Authors:  A M Teitelbaum; S E Murphy; G Akk; T B Baker; A Germann; L B von Weymarn; L J Bierut; A Goate; E D Kharasch; A J Bloom
Journal:  Pharmacogenomics J       Date:  2017-03-14       Impact factor: 3.550

View more
  4 in total

Review 1.  Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions.

Authors:  Slobodan P Rendić; Rachel D Crouch; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2022-06-01       Impact factor: 6.168

Review 2.  Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism.

Authors:  Yadira X Perez-Paramo; Philip Lazarus
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-12-29       Impact factor: 4.481

Review 3.  Flavin-dependent N-hydroxylating enzymes: distribution and application.

Authors:  Carolin Mügge; Thomas Heine; Alvaro Gomez Baraibar; Willem J H van Berkel; Caroline E Paul; Dirk Tischler
Journal:  Appl Microbiol Biotechnol       Date:  2020-06-05       Impact factor: 4.813

4.  Predicting nicotine metabolism across ancestries using genotypes.

Authors:  James W Baurley; Andrew W Bergen; Carolyn M Ervin; Sung-Shim Lani Park; Sharon E Murphy; Christopher S McMahan
Journal:  BMC Genomics       Date:  2022-09-21       Impact factor: 4.547

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.